Clinical Trials Browser

Phase 2 × INDUSTRY × Teratoma × Clear all

NCT02300987 2020-10-26

A Randomized, Blinded, Placebo-controlled, Phase II Trial of LEE011 in Patients With Relapsed, Refractory, Incurable Teratoma With Recent Progression

Phase 2 Completed

10 enrolled 12 charts

Neoplasms, Germ Cell and Embryonal, Teratoma